ES2138574T1 - Composicion inmunogenica de tlp. - Google Patents

Composicion inmunogenica de tlp.

Info

Publication number
ES2138574T1
ES2138574T1 ES97945086T ES97945086T ES2138574T1 ES 2138574 T1 ES2138574 T1 ES 2138574T1 ES 97945086 T ES97945086 T ES 97945086T ES 97945086 T ES97945086 T ES 97945086T ES 2138574 T1 ES2138574 T1 ES 2138574T1
Authority
ES
Spain
Prior art keywords
seq
tlp
fragments
patent number
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES97945086T
Other languages
English (en)
Other versions
ES2138574T3 (es
Inventor
Giulio Istituto Farmacot Tarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unihart Corp
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of ES2138574T1 publication Critical patent/ES2138574T1/es
Application granted granted Critical
Publication of ES2138574T3 publication Critical patent/ES2138574T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/86—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/55—Lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION INMUNOGENA QUE TIENE, COMO MINIMO, UNA PROTEINA EXTRAIDA DE TLP (PARTICULAS LIBERADAS POR EL TUMOR) O UNO DE SUS FRAGMENTOS, Y ESPECIALMENTE LAS COMPOSICIONES EN LAS CUALES DICHOS FRAGMENTOS PUEDEN COMPRENDER, POR LO MENOS, UNO DE LOS PEPTIDOS REIVINDICADOS COMO SEQ ID NO 1, SEQ ID NO 2 Y SEQ ID NO 3 EN LA PATENTE EUROPEA NUMERO 93916141.0 O EL PEPTIDO REIVINDICADO COMO SEQ ID NO 1 EN LA SOLICITUD DE PATENTE ITALIANA NUMERO RM96A000496, CONVINIENDO UNA TERAPIA CONTRA LAS ENFERMEDADES TUMORALES Y ESPECIALMENTE CONTRA EL CANCER DE PULMON SIN PEQUEÑAS CELULAS Y EL CANCER UROGENITAL.
ES97945086T 1996-10-09 1997-10-09 Composicion inmunogenica a base de particulas liberadas por el tumor. Expired - Lifetime ES2138574T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp

Publications (2)

Publication Number Publication Date
ES2138574T1 true ES2138574T1 (es) 2000-01-16
ES2138574T3 ES2138574T3 (es) 2002-11-01

Family

ID=11404462

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97945086T Expired - Lifetime ES2138574T3 (es) 1996-10-09 1997-10-09 Composicion inmunogenica a base de particulas liberadas por el tumor.

Country Status (17)

Country Link
US (2) US20020031531A1 (es)
EP (1) EP0938329B1 (es)
JP (1) JP2001508764A (es)
KR (1) KR20000048995A (es)
CN (1) CN1239431A (es)
AT (1) ATE218064T1 (es)
AU (1) AU725218B2 (es)
CA (1) CA2267905A1 (es)
DE (2) DE938329T1 (es)
DK (1) DK0938329T3 (es)
ES (1) ES2138574T3 (es)
IL (1) IL129368A0 (es)
IT (1) IT1294967B1 (es)
NO (1) NO991653L (es)
PT (1) PT938329E (es)
RU (1) RU2192274C2 (es)
WO (1) WO1998015282A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
RU2192884C2 (ru) * 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Вакцина для стимуляции противоопухолевого иммунитета
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
CA2593086A1 (en) 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
AU2008343758A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
ITRM20100256A1 (it) * 2010-05-19 2011-11-20 Farmafin Spa Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Also Published As

Publication number Publication date
EP0938329A1 (en) 1999-09-01
DE938329T1 (de) 2000-04-06
ITRM960687A1 (it) 1998-04-09
CN1239431A (zh) 1999-12-22
AU725218B2 (en) 2000-10-05
RU2192274C2 (ru) 2002-11-10
US20040022870A1 (en) 2004-02-05
NO991653L (no) 1999-06-08
KR20000048995A (ko) 2000-07-25
ES2138574T3 (es) 2002-11-01
EP0938329B1 (en) 2002-05-29
AU4637697A (en) 1998-05-05
CA2267905A1 (en) 1998-04-16
PT938329E (pt) 2002-10-31
US20020031531A1 (en) 2002-03-14
JP2001508764A (ja) 2001-07-03
DK0938329T3 (da) 2002-09-09
WO1998015282A1 (en) 1998-04-16
IT1294967B1 (it) 1999-04-23
ATE218064T1 (de) 2002-06-15
IL129368A0 (en) 2000-02-17
NO991653D0 (no) 1999-04-08
DE69712907D1 (de) 2002-07-04
DE69712907T2 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
CO5050400A1 (es) Proteina de chlamydia, secuencia de genes y anticuerpos para ello
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ES2564463T3 (es) Péptidos antigénicos de Neisseriales
ES2121791T3 (es) Composicion farmaceutica para el tratamiento o la prevencion de un tumor maligno.
BR0112785A (pt) Peptìdeos de promiostatina e métodos de uso dos mesmos
DE69636450D1 (de) PEPTIDE UND PEPTIDOMIMETIKA MIT STRUKTURELLER ÄHNLICHKEIT MIT p53 UND DIE DIE p53-FUNKTION AKTIVIEREN
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
FI961755A0 (fi) Yhdistelmäadenovirusvektori ja menetelmiä sen käyttämiseksi
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
ES2187756T3 (es) Uso de una composicion farmaceutica que comprende un peptido supresor del apetito.
ZA99133B (en) Transgenic rabbit that expresses a functional human lipoprotein (A).
BRPI0211200B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ES2138574T1 (es) Composicion inmunogenica de tlp.
BRPI0417451A (pt) método de tratar um tumor resistente a interferon
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
ATE326981T1 (de) Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
DK525384D0 (da) Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
EP1978994A4 (en) BMP-7 VARIANTS COMPOSITIONS, METHODS AND USES
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
AU2003234342A8 (en) Ablated slam-dependent entry

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 938329

Country of ref document: ES